Drug Shortage Report for SALOFALK

Last updated on 2022-06-07 History
Report ID 161258
Drug Identification Number 02242146
Brand name SALOFALK
Common or Proper name mesalamine suppository
Company Name APTALIS PHARMA CANADA ULC
Market Status MARKETED
Active Ingredient(s) MESALAZINE
Strength(s) 1G
Dosage form(s) SUPPOSITORY
Route of administration RECTAL RECTAL
Packaging size 30s
ATC code A07EC
ATC description INTESTINALANTIINFLAMMATORY AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-05-25
Actual start date
Estimated end date 2022-06-08
Actual end date 2022-06-06
Shortage status Resolved
Updated date 2022-06-07
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-06-07 English Compare
v5 2022-06-06 French Compare
v4 2022-06-06 English Compare
v3 2022-05-26 English Compare
v2 2022-05-25 French Compare
v1 2022-05-25 English Compare

Showing 1 to 6 of 6